From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer
Dose (mg)
200
400
700
1200
2000a
2000b
2000c
Clinical AE (n)
2
0
6
3
16
7
1
Laboratory AE (n)
20
14
12
25